Atria Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$681K Sell
7,910
-538
-6% -$48.3K 0.01% 1284
2025
Q4
$738K Sell
8,448
-1,218
-13% -$92.4K 0.01% 1230
2025
Q3
$554K Sell
9,666
-297
-3% -$17.1K 0.01% 1362
2025
Q2
$588K Buy
9,963
+2,390
+32% +$154K 0.01% 1330
2025
Q1
$554K Sell
7,573
-18
-0.2% -$1.49K 0.01% 1301
2024
Q4
$628K Sell
7,591
-91
-1% -$7.18K 0.01% 1213
2024
Q3
$550K Sell
7,682
-337
-4% -$23.8K 0.01% 1270
2024
Q2
$549K Buy
+8,019
New +$479K 0.01% 1255
2023
Q1
Sell
-24,347
Closed -$1.81M 837
2022
Q4
$1.81M Buy
24,347
+6,872
+39% +$468K 0.04% 547
2022
Q3
$1.04M Buy
+17,475
New +$1.05M 0.02% 709

Other funds holding GMED

Atria Investments's GMED Position: Q1 2026 in Review

Atria Investments reduced its Globus Medical (GMED) stake by 6.4% in Q1 2026, selling an estimated $48.3K and leaving 7,910 shares worth $681K. The position accounts for 0.01% of the portfolio, ranked #1284.

Atria Investments first reported a position in GMED in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.81M in Q4 2022. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Atria Investments held 7,910 shares of Globus Medical worth $681K as of Q1 2026.
  • Atria Investments sold 538 Globus Medical shares in Q1 2026, an estimated $48.3K.
  • Globus Medical made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1284 holding.
  • Atria Investments first reported a position in Globus Medical in Q3 2022 and has held it in 10 quarters since.
  • Atria Investments's Globus Medical position peaked at $1.81M in Q4 2022.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.